Mangoceuticals (MGRX) Accumulated Expenses (2022 - 2026)

Mangoceuticals has disclosed Accumulated Expenses across 5 years of filings, most recently posting $6634.0 for Q2 2026.

• In Q2 2026, Accumulated Expenses rose 123.14% year-over-year to $6634.0; the TTM figure through Jun 2026 stood at $6634.0 (up 123.14% YoY), while the FY2025 annual figure was $9421.0, changed N/A from the prior year.
• Accumulated Expenses came in at $6634.0 for Q2 2026 at Mangoceuticals, up from $3297.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9421.0 in Q4 2025 to a low of $2717.0 in Q4 2022.
• Average Accumulated Expenses over 5 years is $5639.7, with a median of $5580.0 recorded in 2024.
• Year-over-year, Accumulated Expenses soared 142.73% in 2023 and plunged 36.57% in 2025.
• Over 5 years, Accumulated Expenses stood at $2717.0 in 2022, then soared by 142.73% to $6595.0 in 2023, then declined by 15.39% to $5580.0 in 2024, then soared by 68.84% to $9421.0 in 2025, then dropped by 29.58% to $6634.0 in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $6634.0 in Q2 2026, $3297.0 in Q1 2026, and $9421.0 in Q4 2025.